Cargando…
4-PBA ameliorates cellular homeostasis in fibroblasts from osteogenesis imperfecta patients by enhancing autophagy and stimulating protein secretion
The clinical phenotype in osteogenesis imperfecta (OI) is attributed to the dominant negative function of mutant type I collagen molecules in the extracellular matrix, by altering its structure and function. Intracellular retention of mutant collagen has also been reported, but its effect on cellula...
Autores principales: | Besio, Roberta, Iula, Giusy, Garibaldi, Nadia, Cipolla, Lina, Sabbioneda, Simone, Biggiogera, Marco, Marini, Joan C., Rossi, Antonio, Forlino, Antonella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Pub. Co
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908783/ https://www.ncbi.nlm.nih.gov/pubmed/29432813 http://dx.doi.org/10.1016/j.bbadis.2018.02.002 |
Ejemplares similares
-
Dissecting the phenotypic variability of osteogenesis imperfecta
por: Garibaldi, Nadia, et al.
Publicado: (2022) -
The chaperone activity of 4PBA ameliorates the skeletal phenotype of Chihuahua, a zebrafish model for dominant osteogenesis imperfecta
por: Gioia, Roberta, et al.
Publicado: (2017) -
Intracellular and Extracellular Markers of Lethality in Osteogenesis Imperfecta: A Quantitative Proteomic Approach
por: Bini, Luca, et al.
Publicado: (2021) -
Cellular stress due to impairment of collagen prolyl hydroxylation complex is rescued by the chaperone 4-phenylbutyrate
por: Besio, Roberta, et al.
Publicado: (2019) -
TAPT1—at the crossroads of extracellular matrix and signaling in Osteogenesis imperfecta
por: Etich, Julia, et al.
Publicado: (2023)